Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022 Treating the side-effects of the pandemic Publisert: 24.06.2021 Navamedic ASA (“Navamedic”, OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market Publisert: 17.06.2021 Navamedic ASA: Icepharma new distributor of antibiotics to the Icelandic market Publisert: 07.05.2021 Navamedic ASA: Enters long term distribution agreement for PrecisionBiotics Zenflore® in the Nordics with Novozymes. Publisert: 08.04.2021 MyControl Support – A brand new support program for patients with obesity Publisert: 16.10.2020 FørsteForrige12345NesteSiste
Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022
Navamedic ASA (“Navamedic”, OSE: NAVA) announces it has won the tender for certain antibiotics to the Norwegian hospital market Publisert: 17.06.2021
Navamedic ASA: Icepharma new distributor of antibiotics to the Icelandic market Publisert: 07.05.2021
Navamedic ASA: Enters long term distribution agreement for PrecisionBiotics Zenflore® in the Nordics with Novozymes. Publisert: 08.04.2021